4.3 Article

An Asian multi-national multi-institutional retrospective study comparing intracavitary versus the hybrid of intracavitary and interstitial brachytherapy for locally advanced uterine cervical carcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note

Yuri Shimizu et al.

Summary: This study presented nine cases of uterine cancer patients who underwent HDR-ISBT guided by TR/TA-US for deeply situated tumors out of reach of TRUS. The findings suggest that HDR-ISBT guided with TR/TA-US may achieve favorable local control for gynecologic malignancies with deeply located tumors.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

Configuration analysis of the injection position and shape of the gel spacer in gynecologic brachytherapy

Kotaro Iijima et al.

Summary: This study conducted configuration analysis to determine the optimal location and volume of hyaluronic acid gel spacer injection into the rectovaginal or vesicovaginal septum for effective dose reduction to the rectum and bladder. The results showed that injection of the gel spacer within specific distances and directions predicted a higher dose reduction, with correlations between covering doses and gel spacer parameters. A gel spacer volume of approximately 10 cm³ provides sufficient organ at risk dose reduction if positioned properly.

BRACHYTHERAPY (2021)

Article Oncology

Why not de-intensification for uterine cervical cancer?

Naoya Murakami et al.

Summary: In the management of cervical cancer, low-risk patients can achieve favorable local control with de-escalated treatment intensity. Factors such as tumor reduction ratio, tumor size, and total treatment time can be used to identify these low-risk patients.

GYNECOLOGIC ONCOLOGY (2021)

Article Oncology

Predicting which patients may benefit from the hybrid intracavitary plus interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis

Yesenia Gonzalez et al.

Summary: The study compared the effectiveness of image-guided adaptive brachytherapy plans using different applicators for locally advanced cervical cancer patients. The results showed that using a hybrid applicator like T/R + N could lead to better local control rates and lower bladder and rectum toxicity rates, especially for patients with larger tumor volumes or asymmetric tumor shapes.

BRACHYTHERAPY (2021)

Article Oncology

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

Zachary D. Horne et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial

Daniel A. Hamstra et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)

Editorial Material Oncology

Novel Use of a Hydrogel Spacer Permits Reirradiation in Otherwise Incurable Recurrent Gynecologic Cancers

Akila N. Viswanathan et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Oncology

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer:: Clinical feasibility and preliminary results

Johannes C. A. Dimopoulos et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Oncology

Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix

AMN Syed et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)